Skip to content
Clinical Trials – home
Verifiedinfo

HLPC Haut- und Lasercentrum Potsdam

Germany Kurfürstenstraße 40, 14467 Potsdam, Germany

  • 6 trials recruiting
  • Actinic keratosis · Skin wrinkling · Papulopustular rosacea
  • Adults and children

About Specializations

HLPC Haut- und Lasercentrum Potsdam in Potsdam, Germany specialises in clinical trials of conditions such as Actinic keratosis, Skin wrinkling, Papulopustular rosacea, Acne, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology and Skin Health

The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions. The center's work in this field is characterized by its commitment to developing advanced therapeutic solutions that improve patient outcomes and quality of life.

  • Actinic Keratosis
  • Hidradenitis Suppurativa

By conducting cutting-edge clinical trials, the center contributes significantly to the understanding and management of complex skin disorders, offering hope and improved care for patients worldwide.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kurfürstenstraße 4014467 PotsdamGermany
Recruiting now
6 trials
Conditions studied
9
Partner status
Verified

More sites in PotsdamGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:POTASSIUM HYDROXIDE
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Dermapharm AG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Clindamycin
  • Sponsor:Dermapharm AG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Methylprednisolone Aceponate
  • Sponsor:Dermapharm AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camellia Sinensis (Green Tea) Leaf Extract
  • Sponsor:Aresus Pharma GmbH

Acarodermatitis

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Aesthetics GmbH

Skin wrinkling

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Dantrolene Sodium
  • Sponsor:Fastox Pharma S.A.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:SODIUM BITUMINOSULFONATE DRY SUBSTANCE
  • Sponsor:Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Minoxidil
  • Sponsor:Industrial Farmaceutica Cantabria S.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).